Latest Breaking News On - Ian flinn - Page 3 : comparemela.com

Antibody-Drug Conjugate Targeting ROR1 Shows Activity in DLBCL

Ian Flinn, MD, PhD, leads a discussion on the promising early data for zilovertamab vedotin

United statesDana farber cancer instituteCarona jacobsonJason westinIan flinnSarah cannon research institute in nashvilleUniversity of texas md anderson cancer centerAmerican society of clinical oncologyAmerican societyClinical oncologyPage todayModerator ian flinnSarah cannon research instituteCancer center

Bispecific Antibodies in Relapsed/Refractory DLBCL

Ian Flinn leads a discussion on epcoritamab, which was recently FDA approved

Dana farber cancer instituteUnited statesJason westinCarona jacobsonIan flinnUniversity of texas md anderson cancer centerAmerican society of clinical oncologySarah cannon research institute in nashvilleAmerican societyClinical oncologyPage todayModerator ian flinnSarah cannon research instituteCancer center

Second-Line CAR-T Improves Survival in Large B-Cell Lymphoma

Ian Flinn, MD, PhD, leads a discussion on ZUMA-7 and the upcoming ZUMA-23 with the study authors

United statesDana farber cancer instituteIan flinnJason westinCarona jacobsonUniversity of texas md anderson cancer centerAmerican society of clinical oncologySarah cannon research institute in nashvilleAmerican societyClinical oncologyNew england journalPage todayModerator ian flinnSarah cannon research instituteCancer center

Including Polatuzumab Vedotin in First-Line DLBCL Treatment

Ian Flinn, MD, PhD, leads a discussion on the future successors to the current standard of care

United statesDana farber cancer instituteJason westinCaron jacobsonCarona jacobsonIan flinnGreg laubMd anderson cancer centerUniversity of texas md anderson cancer centerSarah cannon research instituteSarah cannon research institute in nashvilleAmerican society of clinical oncologyAmerican societyClinical oncologyPage todayModerator ian flinn

Nurix Therapeutics Will Present Trial in Progress Posters for Two Clinical Programs at the 2022 Annual European Hematology Association (EHA) Congress

Nurix Therapeutics Will Present Trial in Progress Posters for Two Clinical Programs at the 2022 Annual European Hematology Association (EHA) Congress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSan franciscoDima el sharkawiWilliamg wierdasessionKrish patelSrinand nandakumarSusan obrien srinand nandakumarErin meredithSu young kimBrett whelanAlexey danilovJeanette doorduijnsessionAdrian wiestnerGrahamp collinsKatherinel jameson